Ruthia He was found guilty of conspiring to distribute controlled substances after Done Global, her ADHD startup, became a ready source of Adderall prescriptions https://t.co/o1jTih50Q9 ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Oaktree Specialty Lending (NasdaqGS:OCSL) Q4 2025 Earnings Call November 18, 2025 11:00 AM ET Company ParticipantsArmen Panossian - CEO and CIORaghav Khanna - Co-CIOClark Koury - Head of Investor RelationsMatt Pendo - President and COOChris McKown - CFO and TreasurerConference Call ParticipantsMelissa Waddell - Research AnalystSean Paul Adams - Research AnalystOperatorWelcome, and thank you for joining Oaktree Specialty Lending Corporation's Fourth Fiscal Quarter and Full Year 2025 conference call. Today's ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Group 1 - Diodes (DIOD) is a leading manufacturer and supplier of high-quality discrete and analog semiconductor products, primarily serving the communications, computing, industrial, consumer electronics, and automotive markets [1] - The Zacks Consensus Estimate for Diodes' current year earnings has been revised 12.2% downward over the last 60 days [1] Group 2 - Ardent Health, Inc. (ARDT) is a provider of healthcare services [2] - The Zacks Consensus Estimate for Ardent Health's current year earnings has been revised almost 8.8% downward over the last 60 days [2] Group 3 - F5 (FFIV) provides products and services to manage Internet traffic worldwide [2] - The Zacks Consensus Estimate for F5's current year earnings has been revised almost 6.3% downward over the last 60 days [2]

Economic Outlook - The Federal Reserve has begun cutting interest rates in 2025, which is expected to benefit the average American and enhance borrowing power for businesses, potentially leading to a rise in stock market investments [1] - As economic factors converge heading into 2026, investors with low risk tolerance may seek stability, with certain sectors expected to provide safety and growth to hedge against inflation [2] Stock Market Volatility - The stock market is experiencing volatility due to tariffs, inflation concerns, and government shutdowns, with the volatility index (VIX) reaching 22.44 on October 10, 2025, after hovering between 15 and 17 points since June [3] - The VIX is described as a measure of institutional hedging activity rather than a fear gauge, indicating that while institutional investors may be cautious, they are not overly fearful [4] Sector Analysis Health Care - The health care sector is identified as poised for growth, with fair valuations and ongoing health needs due to an aging population, making it recession-resistant [5] - AI-powered healthcare platforms are projected to perform exceptionally well, with the market expected to reach $504 billion by 2032 [5] Retail - The retail sector, particularly apparel and retail stocks, is anticipated to show stability, with historical returns of 27.3% and 25.8% respectively during previous falling interest rate environments [7] - Consumer discretionary and luxury goods sectors may face challenges, but overall retail is expected to remain stable [7] Investment Recommendations - Companies such as Zepp Health Corporation, OptimizeRX Corporation, and Veeva Systems are rated as "strong buys," indicating positive investment opportunities within the health care sector [6]

Key Takeaways CVS Health reported $103B Q3 revenues and a 47% EPS surge, beating estimates for the third straight quarter.CVS raised its 2025 forecast, projecting higher adjusted EPS and revenues on broad segment strength.CVS Health saw gains across Aetna, Health Care Delivery and Pharmacy while noting cost and macro pressures.CVS Health (CVS) continues to enjoy the strength of its diversified businesses. Third-quarter 2025 revenues hit a record $103 billion, up 8% year over year, with all segments contribu ...

Venture capitalist Jim Breyer made his first billion from Facebook two decades ago when it was far from a sure thing. Now, with his two adult sons as partners and a family tragedy behind him, he’s got another big win and ambitions to reinvent healthcare. (Photo: Cody Pickens for Forbes) https://t.co/AS7iw0hYAl ...

REDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for its second quarter of fiscal 2026, ended September 30, 2025. Leveraging best-in-class technology, strategic execution, and automation-driven operational efficiencies to mai ...